In a woman receiving teriparatide with vitamin D, calcium, and alendronate discontinuation, thigh pain improved by 1 month and disappeared by 9 months.
In plain wordsIn one woman, thigh pain improved during teriparatide treatment with vitamin D, calcium, and alendronate discontinuation.
- Peptide
- Teriparatide (PTH 1-34)
- Outcome
- DecreaseThigh pain
- Study
n = 1
- Comparator
- Before treatment
- Outcome group
- Pain · Musculoskeletal
Source sentences
Pain and tenderness improved remarkably after teriparatide treatment for 1 month, and these symptoms disappeared after teriparatide treatment for 9 months.
5 context sentences(design, population, supporting numbers)
A 63-year-old Asian woman had a lumbar osteoporotic fracture and received 70 mg of alendronate for 3 years.
X-ray revealed a right femoral diaphysis stress fracture.
She then received teriparatide for the treatment of osteoporosis and the femoral atypical fracture.
Even though a previous study has reported that teriparatide healed stress fractures in a rat model and even with the time course of fracture healing in our patient, we are still not certain that teriparatide played a primary role in the positive response to therapy.
Vitamin D therapy, calcium, and alendronate discontinuation may have played secondary roles.
In this study, Teriparatide (PTH 1-34) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Teriparatide (PTH 1-34).